title: Monoclonal antibodies targeting PCSK9 and the search for prolonged duration of effect.
authors.affiliation: Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA pridker@partners.org.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ridker
mesh_terms: D000911:Antibodies, Monoclonal; D008078:Cholesterol, LDL; D002986:Clinical Trials as Topic; D006801:Humans; D018345:Mice, Knockout; D018832:Molecular Chaperones; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D034741:RNA, Small Interfering
chemical_list: D000911:Antibodies, Monoclonal; D008078:Cholesterol, LDL; D018832:Molecular Chaperones; D034741:RNA, Small Interfering; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases